Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07708181 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of SSGJ-613 in Gout Participants Initiating Urate-Lowering Treatment

StatusNot Yet Recruiting
PhasePhase 2
Started2026-08-02
View on ClinicalTrials.gov ↗

Amendment history

2026-07-16
Study Status, Eligibility v1
Eligibility criteria+1 characters
[...] ks prior to the start of the study. Use of forbidden therapy.
2026-07-12
Original filing
The purpose of this study is to determine the efficacy and safety of recombinant anti-interleukin-1β humanized monoclonal antibody injection in Chinese gout participants Initiating Urate-Lowering Treatment
Trial Details
NCT Number NCT07708181
Lead Sponsor Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions Gout Arthritis
Enrollment 200 participants
Start Date 2026-08-02
Primary Completion 2027-08-11 (estimated)
Study Completion 2028-04-19 (estimated)
Updated on ClinicalTrials.gov 2026-07-20